State Street SPDR S&P Pharmaceuticals ETF XPH
64.16 USD -1.20 (-1.84%)
Regular-session close
63.73 -0.43 -0.67%
After hours · Nov 17, 4:00 PM ET
63.82 Day range 65.18
51.09 52-week range 74.35
- YTD
- +14.55%
- 1 year
- +24.85%
News
fool.com Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB? State Street SPDR S&P Pharmaceuticals ETF has a lower expense ratio and a higher trailing dividend yield. iShares Biotechnology ETF is significantly larger by assets under management.
fool.com Which Healthcare ETF Is Best for the Long Term: State Street’s XPH or Invesco’s PBE? Lower fees and a steadier beta set one healthcare ETF apart, while the rival fund's richer dividend could sway income-focused investors.
fool.com Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street’s XPH or First Trust’s FBT? One fund holds about 60 drug companies at a lower fee. The other holds 30 biotech names and has a stronger long-term record. Either way, expect some volatility.
